Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

ENvironmental Dynamics Underlying Responsive Extreme Survivors (ENDURES) of Glioblastoma: A Multidisciplinary Team-based, Multifactorial Analytical Approach.

Johnston SK, Whitmire P, Massey SC, Kumthekar P, Porter AB, Raghunand N, Gonzalez-Cuyar LF, Mrugala MM, Hawkins-Daarud A, Jackson PR, Hu LS, Sarkaria JN, Wang L, Gatenby RA, Egan KM, Canoll P, Swanson KR; ENDURES consortium.

Am J Clin Oncol. 2019 Aug;42(8):655-661. doi: 10.1097/COC.0000000000000564.

PMID:
31343422
2.

Integration of machine learning and mechanistic models accurately predicts variation in cell density of glioblastoma using multiparametric MRI.

Gaw N, Hawkins-Daarud A, Hu LS, Yoon H, Wang L, Xu Y, Jackson PR, Singleton KW, Baxter LC, Eschbacher J, Gonzales A, Nespodzany A, Smith K, Nakaji P, Mitchell JR, Wu T, Swanson KR, Li J.

Sci Rep. 2019 Jul 11;9(1):10063. doi: 10.1038/s41598-019-46296-4.

3.

Improved model prediction of glioma growth utilizing tissue-specific boundary effects.

Jacobs J, Rockne RC, Hawkins-Daarud AJ, Jackson PR, Johnston SK, Kinahan P, Swanson KR.

Math Biosci. 2019 Jun;312:59-66. doi: 10.1016/j.mbs.2019.04.004. Epub 2019 Apr 19.

PMID:
31009624
4.

A Transgenerational Perspective on Prevention and Treatment of Adolescent Substance Use Disorders.

Jackson PR.

J Child Adolesc Psychopharmacol. 2019 Aug;29(7):477-478. doi: 10.1089/cap.2018.0174. Epub 2019 Apr 10. No abstract available.

PMID:
30969132
5.

Multiparameter MRI Predictors of Long-Term Survival in Glioblastoma Multiforme.

Stringfield O, Arrington JA, Johnston SK, Rognin NG, Peeri NC, Balagurunathan Y, Jackson PR, Clark-Swanson KR, Swanson KR, Egan KM, Gatenby RA, Raghunand N.

Tomography. 2019 Mar;5(1):135-144. doi: 10.18383/j.tom.2018.00052.

6.

Accurate Patient-Specific Machine Learning Models of Glioblastoma Invasion Using Transfer Learning.

Hu LS, Yoon H, Eschbacher JM, Baxter LC, Dueck AC, Nespodzany A, Smith KA, Nakaji P, Xu Y, Wang L, Karis JP, Hawkins-Daarud AJ, Singleton KW, Jackson PR, Anderies BJ, Bendok BR, Zimmerman RS, Quarles C, Porter-Umphrey AB, Mrugala MM, Sharma A, Hoxworth JM, Sattur MG, Sanai N, Koulemberis PE, Krishna C, Mitchell JR, Wu T, Tran NL, Swanson KR, Li J.

AJNR Am J Neuroradiol. 2019 Mar;40(3):418-425. doi: 10.3174/ajnr.A5981. Epub 2019 Feb 28.

7.

Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma.

Randall EC, Emdal KB, Laramy JK, Kim M, Roos A, Calligaris D, Regan MS, Gupta SK, Mladek AC, Carlson BL, Johnson AJ, Lu FK, Xie XS, Joughin BA, Reddy RJ, Peng S, Abdelmoula WM, Jackson PR, Kolluri A, Kellersberger KA, Agar JN, Lauffenburger DA, Swanson KR, Tran NL, Elmquist WF, White FM, Sarkaria JN, Agar NYR.

Nat Commun. 2018 Nov 21;9(1):4904. doi: 10.1038/s41467-018-07334-3.

8.

Identifying and Eliminating Sources of Recreational Water Quality Degradation along an Urban Coast.

Nevers MB, Byappanahalli MN, Shively D, Buszka PM, Jackson PR, Phanikumar MS.

J Environ Qual. 2018 Sep;47(5):1042-1050. doi: 10.2134/jeq2017.11.0461.

PMID:
30272790
9.

Team science and the physician-scientist in the age of grand health challenges.

Steer CJ, Jackson PR, Hornbeak H, McKay CK, Sriramarao P, Murtaugh MP.

Ann N Y Acad Sci. 2017 Sep;1404(1):3-16. doi: 10.1111/nyas.13498. Review.

10.

A Laboratory Investigation of the Suspension, Transport, and Settling of Silver Carp Eggs Using Synthetic Surrogates.

Garcia T, Zuniga Zamalloa C, Jackson PR, Murphy EA, Garcia MH.

PLoS One. 2015 Dec 29;10(12):e0145775. doi: 10.1371/journal.pone.0145775. eCollection 2015.

11.

Implications of Climate Change on the Heat Budget of Lentic Systems Used for Power Station Cooling: Case Study Clinton Lake, Illinois.

Quijano JC, Jackson PR, Santacruz S, Morales VM, García MH.

Environ Sci Technol. 2016 Jan 5;50(1):478-88. doi: 10.1021/acs.est.5b04094. Epub 2015 Dec 17.

PMID:
26556581
12.

Patient-specific mathematical neuro-oncology: using a simple proliferation and invasion tumor model to inform clinical practice.

Jackson PR, Juliano J, Hawkins-Daarud A, Rockne RC, Swanson KR.

Bull Math Biol. 2015 May;77(5):846-56. doi: 10.1007/s11538-015-0067-7. Epub 2015 Mar 21. Review.

13.

The new Sheffield risk and benefit tables for the elderly.

Weatherley ND, Jackson PR.

QJM. 2011 Jan;104(1):3-12. doi: 10.1093/qjmed/hcq167. Epub 2010 Sep 17. Review.

PMID:
20851821
14.

A novel size-selective airborne particle size fractionating instrument for health risk evaluation.

Gorbunov B, Priest ND, Muir RB, Jackson PR, Gnewuch H.

Ann Occup Hyg. 2009 Apr;53(3):225-37. doi: 10.1093/annhyg/mep002. Epub 2009 Mar 11.

15.

Density currents in the Chicago River: characterization, effects on water quality, and potential sources.

Jackson PR, García CM, Oberg KA, Johnson KK, García MH.

Sci Total Environ. 2008 Aug 15;401(1-3):130-43. doi: 10.1016/j.scitotenv.2008.04.011. Epub 2008 May 22.

PMID:
18499229
16.

Is the association of hypertension and panic disorder explained by clustering of autonomic panic symptoms in hypertensive patients?

Davies SJ, Jackson PR, Lewis G, Hood SD, Nutt DJ, Potokar JP.

J Affect Disord. 2008 Dec;111(2-3):344-50. doi: 10.1016/j.jad.2008.03.003. Epub 2008 Apr 29.

PMID:
18448170
17.

Patients' acceptance of antihypertensive therapy to prevent cardiovascular disease: a comparison between South Asians and Caucasians in the United Kingdom.

Aarabi M, Skinner J, Price CE, Jackson PR.

Eur J Cardiovasc Prev Rehabil. 2008 Feb;15(1):59-66. doi: 10.1097/HJR.0b013e3282f07973.

PMID:
18277187
18.

The effect of GSM and TETRA mobile handset signals on blood pressure, catechol levels and heart rate variability.

Barker AT, Jackson PR, Parry H, Coulton LA, Cook GG, Wood SM.

Bioelectromagnetics. 2007 Sep;28(6):433-8.

PMID:
17486598
19.

Prevention of coronary heart disease with statins in UK South Asians and Caucasians.

Aarabi M, Jackson PR.

Eur J Cardiovasc Prev Rehabil. 2007 Apr;14(2):333-9.

PMID:
17446816
20.

Survey of intensive care physicians on the recognition and management of intra-abdominal hypertension and abdominal compartment syndrome.

Kimball EJ, Rollins MD, Mone MC, Hansen HJ, Baraghoshi GK, Johnston C, Day ES, Jackson PR, Payne M, Barton RG.

Crit Care Med. 2006 Sep;34(9):2340-8.

PMID:
16878034
21.

Depleting serotonin enhances both cardiovascular and psychological stress reactivity in recovered patients with anxiety disorders.

Davies SJ, Hood SD, Argyropoulos SV, Morris K, Bell C, Witchel HJ, Jackson PR, Nutt DJ, Potokar JP.

J Clin Psychopharmacol. 2006 Aug;26(4):414-8.

PMID:
16855462
22.

Call centers as lean service environments: job-related strain and the mediating role of work design.

Sprigg CA, Jackson PR.

J Occup Health Psychol. 2006 Apr;11(2):197-212.

PMID:
16649852
23.

Cardiovascular risk assessment.

Jackson PR.

Lancet. 2005 Apr 9-15;365(9467):1306. No abstract available.

PMID:
15823377
24.

Predicting coronary risk in UK South Asians: an adjustment method for Framingham-based tools.

Aarabi M, Jackson PR.

Eur J Cardiovasc Prev Rehabil. 2005 Feb;12(1):46-51.

PMID:
15703505
25.

Coronary risk in South Asians: role of ethnicity and blood sugar.

Aarabi M, Jackson PR.

Eur J Cardiovasc Prev Rehabil. 2004 Oct;11(5):389-93. Review.

PMID:
15616411
26.

If it doesn't work, stop it: "ineffective" treatments might be in a patient's best interests.

Jackson PR.

BMJ. 2004 Apr 24;328(7446):1015; discussion 1016. No abstract available.

27.

Treatment of anxiety and depressive disorders in patients with cardiovascular disease.

Davies SJ, Jackson PR, Potokar J, Nutt DJ.

BMJ. 2004 Apr 17;328(7445):939-43. Review. No abstract available.

28.
29.

No evidence that panic attacks are associated with the white coat effect in hypertension.

Davies SJ, Jackson PR, Ramsay LE, Ghahramani P, Palmer RL, Hippisley-Cox J.

J Clin Hypertens (Greenwich). 2003 Mar-Apr;5(2):145-52.

30.

Drug intolerance due to nonspecific adverse effects related to psychiatric morbidity in hypertensive patients.

Davies SJ, Jackson PR, Ramsay LE, Ghahramani P.

Arch Intern Med. 2003 Mar 10;163(5):592-600.

PMID:
12622606
31.

Risk factors for non-haemorrhagic stroke and the effect of lipid-modifying therapy.

Jackson PR.

J Hypertens. 2002 Dec;20(12):2359-62. Review. No abstract available.

PMID:
12473858
32.

Coronary and cardiovascular risk estimation in uncomplicated mild hypertension. A comparison of risk assessment methods.

Yikona JI, Wallis EJ, Ramsay LE, Jackson PR.

J Hypertens. 2002 Nov;20(11):2173-82.

PMID:
12409955
33.

Cardiovascular and coronary risk estimation in hypertension management.

Wallis EJ, Ramsay LE, Jackson PR.

Heart. 2002 Sep;88(3):306-12. Review. No abstract available.

34.

Economics of drug treatment.

Jackson PR.

Lancet. 2002 Mar 9;359(9309):892-3. No abstract available.

PMID:
11897317
35.

What benefit do patients expect from adding second and third antihypertensive drugs?

Leaman H, Jackson PR.

Br J Clin Pharmacol. 2002 Jan;53(1):93-9.

36.

First-line treatment for hypertension.

Jackson PR, Ramsay LE; United States JNC VI and British Hypertension Society Guideline; International WHO/ISH Guideline.

Eur Heart J. 2002 Feb;23(3):179-82. No abstract available.

PMID:
11792127
37.

Statins for primary prevention: at what coronary risk is safety assured?

Jackson PR, Wallis EJ, Haq IU, Ramsay LE.

Br J Clin Pharmacol. 2001 Oct;52(4):439-46.

38.

Dysfunctional breathing and asthma. Panic disorder needs to be considered.

Davies SJ, Jackson PR, Ramsay LE.

BMJ. 2001 Sep 15;323(7313):631; author reply 631-2. No abstract available.

39.
40.

Prevention of stroke and transient ischaemic attack.

Jackson PR, Wallis EJ, Ramsay LE.

Lancet. 2001 Sep 1;358(9283):762. No abstract available.

PMID:
11556348
41.

Population implications of lipid lowering for prevention of coronary heart disease: data from the 1995 Scottish health survey.

Haq IU, Ramsay LE, Wallis EJ, Isles CG, Ritchie LD, Jackson PR.

Heart. 2001 Sep;86(3):289-95.

42.

Is coronary risk an accurate surrogate for cardiovascular risk for treatment decisions in mild hypertension? A population validation.

Wallis EJ, Ramsay LE, Haq IU, Ghahramani P, Jackson PR.

J Hypertens. 2001 Apr;19(4):691-6.

PMID:
11330871
43.

Cholesterol-lowering therapy for smokers.

Jackson PR.

Lancet. 2001 Mar 24;357(9260):960. No abstract available.

PMID:
11289375
44.

Aspirin for primary prevention. Treatment policy should be based on all trial evidence, not subgroup analysis.

Ramsay LE, Sanmuganathan PS, Wallis EJ, Jackson PR.

BMJ. 2000 Dec 9;321(7274):1472. No abstract available.

45.
46.

Optimal age for starting lipid lowering treatment. Adjusted date do not justify a lower optimal age.

Jackson PR, Wallis EJ, Ramsay LE.

BMJ. 2000 Sep 9;321(7261):637-8. No abstract available.

PMID:
11023329
47.

Comparison of methods of estimating coronary risk. Authors did not use latest version of Sheffield table.

Wallis EJ, Ramsay LE, Yikona JI, Jackson PR.

BMJ. 2000 Jul 15;321(7254):175-6. No abstract available.

48.

Debate: at what level of coronary heart disease risk should a statin be prescribed?

Jackson PR, Ramsay LE.

Curr Opin Lipidol. 2000 Aug;11(4):357-61. Review.

PMID:
10945716
49.

Lean production teams and health in garment manufacture.

Jackson PR, Mullarkey S.

J Occup Health Psychol. 2000 Apr;5(2):231-45.

PMID:
10784287
50.

Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population.

Wallis EJ, Ramsay LE, Ul Haq I, Ghahramani P, Jackson PR, Rowland-Yeo K, Yeo WW.

BMJ. 2000 Mar 11;320(7236):671-6. Erratum in: BMJ 2000 Apr 15;320(7241):1034.

Supplemental Content

Loading ...
Support Center